journal article·2021-10

A Novel Immunomodulator Delivery Platform Based on Bacterial Biomimetic Vesicles for Enhanced Antitumor Immunity

Liangqun Hua, Zhongqian Yang, Weiran Li, Qishu Zhang, Zhaoling Ren, Chao Ye, Xiao Zheng, Duo Li, Qiong Long, Hongmei Bai, Wenjia Sun, Xu Yang, Peng Zheng, Jinrong He, Yongjun Chen, Weiwei Huang, Yanbing Ma

Advanced Materials· Volume 33· Issue 43
Publisher page

Abstract

Abstract T cell activation‐induced cell death (AICD) during tumor pathogenesis is a tumor immune escape process dependent on dendritic cells (DCs). Proper immune‐modulatory therapies effectively inhibit tumor‐specific CD8+ T cell exhaustion and enhance antitumor immune responses. Here, high‐pressure homogenization is utilized to drive immunomodulator IL10‐modified bacteria to extrude through the gap and self‐assemble into bacterial biomimetic vesicles exposing IL10 (IL10‐BBVs) on the surface with high efficiency. IL10‐BBVs efficiently target DCs in tumor‐draining lymph nodes and thus increase the interaction between IL10 on BBVs and IL10R on DCs to suppress AICD and mitigate CD8+ T cell exhaustion specific to tumor antigens. Two subcutaneous peripheral injections of IL10‐BBVs 1 week apart in tumor‐bearing mice effectively increase systemic and intratumoral proportions of CD8+ T cells to suppress tumor growth and metastasis. Tumor‐specific antigen E7 is enclosed into the periplasm of IL10‐BBVs (IL10‐E7‐BBVs) to realize concurrent actions of the immunomodulator IL10 and the tumor antigen human papillomavirus (HPV) 16E7 in lymph nodes, further enhancing the antitumor effects mediated by CD8+ T cells. The development of this modified BBV delivery platform will expand the application of bacterial membranes and provide novel immunotherapeutic strategies for tumor treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Cancer Research and Treatments · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Molecular Immunology Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College 935 Jiaoling Road Kunming 650118 China

School of Life Sciences Yunnan University 2 Cuihu North Road Kunming 650091 China

The Second Affiliated Hospital of Kunming Medical University 374 Dian Burma Avenue Kunming 650101 China

Department of Acute Infectious Diseases Control and Prevention Yunnan Provincial Center for Disease Control and Prevention 158 Dongsi Street Kunming 530112 China

Kunming Medical University 1168 Chunrong West Road Kunming 650500 China

Funding

National Natural Science Foundation of China

References (76)

Show source-provided references
1. 10.1053/j.gastro.2010.10.00910.1053/j.gastro.2010.10.009 ↗
2. 10.1038/nri193610.1038/nri1936 ↗
3. 10.1016/j.ccell.2018.03.00810.1016/j.ccell.2018.03.008 ↗
4. 10.1146/annurev-immunol-032414-11204310.1146/annurev-immunol-032414-112043 ↗
5. 10.1016/j.it.2016.09.00610.1016/j.it.2016.09.006 ↗
6. 10.1016/j.ccell.2019.05.00510.1016/j.ccell.2019.05.005 ↗
7. 10.1016/j.immuni.2016.07.01110.1016/j.immuni.2016.07.011 ↗
8. 10.1038/s41586-019-1324-y10.1038/s41586-019-1324-y ↗
9. 10.1172/JCI2616910.1172/JCI26169 ↗
10. 10.1016/j.immuni.2019.03.02010.1016/j.immuni.2019.03.020 ↗
11. 10.1016/j.immuni.2011.09.01710.1016/j.immuni.2011.09.017 ↗
12. 10.1158/2326-6066.CIR-13-021410.1158/2326-6066.CIR-13-0214 ↗
13. 10.1111/j.1600-065X.2008.00635.x10.1111/j.1600-065X.2008.00635.x ↗
14. 10.1038/s41590-019-0346-910.1038/s41590-019-0346-9 ↗
15. 10.1016/j.ccr.2011.11.00310.1016/j.ccr.2011.11.003 ↗
16. 10.1016/j.canlet.2015.07.00910.1016/j.canlet.2015.07.009 ↗
17. 10.1021/acsnano.0c0310910.1021/acsnano.0c03109 ↗
18. 10.1002/adma.20170535010.1002/adma.201705350 ↗
19. 10.1021/acs.accounts.9b0011610.1021/acs.accounts.9b00116 ↗
20. 10.1002/adma.20170675910.1002/adma.201706759 ↗
21. 10.1038/s41467-021-22308-810.1038/s41467-021-22308-8 ↗
22. 10.1016/j.addr.2017.05.00310.1016/j.addr.2017.05.003 ↗
23. 10.1016/S0092-8674(03)00754-210.1016/S0092-8674(03)00754-2 ↗
24. 10.1021/acs.accounts.0c0055110.1021/acs.accounts.0c00551 ↗
25. 10.1021/acsnano.0c0377610.1021/acsnano.0c03776 ↗
26. 10.1016/j.biomaterials.2016.07.00310.1016/j.biomaterials.2016.07.003 ↗
27. 10.1038/nri383710.1038/nri3837 ↗
28. 10.1002/adma.20200208510.1002/adma.202002085 ↗
29. 10.1371/journal.ppat.100379710.1371/journal.ppat.1003797 ↗
30. 10.1038/nature0647910.1038/nature06479 ↗
31. 10.1016/j.jmb.2008.03.07610.1016/j.jmb.2008.03.076 ↗
32. 10.1084/jem.2019041810.1084/jem.20190418 ↗
33. 10.1021/acsnano.8b0096710.1021/acsnano.8b00967 ↗
34. 10.1158/0008-5472.CAN-16-138710.1158/0008-5472.CAN-16-1387 ↗
35. 10.1038/s41568-019-0235-410.1038/s41568-019-0235-4 ↗
36. 10.1038/ni.203510.1038/ni.2035 ↗
37. 10.1038/s41577-019-0224-610.1038/s41577-019-0224-6 ↗
38. 10.1016/j.it.2011.05.00310.1016/j.it.2011.05.003 ↗
39. 10.1016/j.ccell.2018.10.00710.1016/j.ccell.2018.10.007 ↗
40. 10.1016/j.biomaterials.2018.06.01510.1016/j.biomaterials.2018.06.015 ↗
41. 10.1016/j.arr.2017.03.00810.1016/j.arr.2017.03.008 ↗
42. 10.1016/j.ccell.2021.02.01310.1016/j.ccell.2021.02.013 ↗
43. 10.1056/NEJMoa100346610.1056/NEJMoa1003466 ↗
44. 10.1056/NEJMoa130236910.1056/NEJMoa1302369 ↗
45. 10.1016/S1470-2045(19)30689-810.1016/S1470-2045(19)30689-8 ↗
46. 10.1038/s41586-020-03054-110.1038/s41586-020-03054-1 ↗
47. 10.1126/scisignal.abc065310.1126/scisignal.abc0653 ↗
48. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
49. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
50. 10.1002/adma.20160603610.1002/adma.201606036 ↗
51. 10.1021/acs.accounts.9b0014810.1021/acs.accounts.9b00148 ↗
52. 10.1021/acsnano.6b0645110.1021/acsnano.6b06451 ↗
53. 10.1038/s41467-017-00729-810.1038/s41467-017-00729-8 ↗
54. 10.1038/s41467-019-09034-y10.1038/s41467-019-09034-y ↗
55. 10.1002/adma.20190404010.1002/adma.201904040 ↗
56. 10.1021/nn405724x10.1021/nn405724x ↗
57. 10.1016/j.nantod.2020.10100710.1016/j.nantod.2020.101007 ↗
58. 10.1002/adma.20190818510.1002/adma.201908185 ↗
59. 10.1002/adma.20170142910.1002/adma.201701429 ↗
60. 10.1021/acs.nanolett.8b0189210.1021/acs.nanolett.8b01892 ↗
61. 10.1002/adma.20180223310.1002/adma.201802233 ↗
62. 10.1016/j.biomaterials.2018.01.01810.1016/j.biomaterials.2018.01.018 ↗
63. 10.1038/nature1537310.1038/nature15373 ↗
64. 10.1039/c3nr01541f10.1039/c3nr01541f ↗
65. 10.1002/adma.20190117910.1002/adma.201901179 ↗
66. 10.1021/acsnano.7b0904110.1021/acsnano.7b09041 ↗
67. 10.1038/nbt102910.1038/nbt1029 ↗
68. 10.1089/ars.2014.584910.1089/ars.2014.5849 ↗
69. 10.1002/anie.20120133710.1002/anie.201201337 ↗
70. 10.1038/nature0802610.1038/nature08026 ↗
71. 10.1038/ncomms719810.1038/ncomms7198 ↗
72. Gracht E. T. · J. Immunother. Cancer · 2020 · 810.1136/jitc-2020-001133 ↗
73. 10.1016/j.actbio.2019.04.03310.1016/j.actbio.2019.04.033 ↗
74. 10.1073/pnas.171834111510.1073/pnas.1718341115 ↗
75. 10.1016/j.jconrel.2019.11.01710.1016/j.jconrel.2019.11.017 ↗
76. 10.1002/adma.20200452910.1002/adma.202004529 ↗